Heron Therapeutics shares owned by Connor, Clark & Lunn Investment Management
Quarter-by-quarter ownership of Heron Therapeutics (HRTX) shares owned by Connor, Clark & Lunn Investment Management
from 13F filings
Historical chart of Connor, Clark & Lunn Investment Management investment in Heron Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Heron Therapeutics held by Connor, Clark & Lunn Investment Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Heron Therapeutics by Connor, Clark & Lunn Investment Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $106k | 84k | 1.26 |
| 2022-12-31 | $158k | 63k | 2.50 |
| 2022-09-30 | $965k | 229k | 4.22 |
| 2022-03-31 | $720k | 126k | 5.72 |
| 2015-03-31 | $686k | 37k | 18.44 |
More positions owned by Connor, Clark & Lunn Investment Management
View all positions for Connor, Clark & Lunn Investment Management